another good night on nasdaq, page-48

""CAN003, the current Phase 2b trial is being done on the basis of comparison to OSC, hence CAN004 needs to include the placebo arm in the trial, and accordingly has been designated as Phase 2/3.""

There you go you have confirmed it to yourself and everyone here that they are still working through Phase 2 "Establishing the efficacy of the drug, usually against a placebo" as I have said all along re it being a Phase 2 because it is listed as a Phase2/3 in the US and a Phase 2 in Europe. Don't you need to successfully pass through a Phase 2 before you can commence Phase 3 read you own post.

Maybe you can explain to your followers here why the trials listed below don't conform with you theory/post....re comparing the Active Comparator to the Placebo Comparator in a Phase 3 yes not a Phase2/3 ...let me guess it's a software problem with the site.

Last post for a while wasting time again.

http://www.clinicaltrials.gov/ct2/show/NCT00994110?term=placebo&rank=4

http://www.clinicaltrials.gov/ct2/show/NCT01291433?term=placebo&rank=6

http://www.clinicaltrials.gov/ct2/show/NCT00790036?term=placebo&rank=27

http://www.clinicaltrials.gov/ct2/show/NCT00637494?term=placebo&rank=81

http://www.clinicaltrials.gov/ct2/show/NCT01599975?term=placebo&rank=84